-
Industry: New medical infrastructure is in full swing, and 2023 will still be the peak of medical device procurement
Time of Update: 2023-02-01
According to the list of loan projects that have been reported and approved so far, the industry expects that the demand for medical equipment loans will be about 200 billion yuan nationwide, which will be enough to make up for the lack of cash flow caused by the pressure on the hospital's diagnosis and treatment volume, and there is a certain net increment.
-
Focus on nutrition for special populations and popularize the concept of national health
Time of Update: 2022-11-14
However, in patients with type 1 diabetes, plasma glucagon levels increase after intake of a high-protein diet, while insufficient insulin secretion leads to an increase in postprandial blood sugar.
-
Suture needle puncture force tester YY 0043 - 2015 test requirements
Time of Update: 2022-10-03
General medical device testing equipment suppliers basically have these products, find medical device testing equipment suppliers can purchase the goods you needSuture needles are commonly found in the garment industry, but in the field of medical surgery, suture needles are also very important medical device equipment, and suture needles are mostly called medical sutures in the medical field.
-
Make the weapons of cancer cells harmless
Time of Update: 2022-09-09
"Instead, ATP will accumulate around cancer cells, which actually stimulates the immune response," Müller said.
"Instead, ATP will accumulate around cancer cells, which actually stimulates the immune response," Müller said.
"Instead, ATP will accumulate around cancer cells, which actually stimulates the immune response," Müller said.
-
South Korea cancels import tariffs on masks and meltblown cloth, and the first batch of materials donated by Wuhan arrives in South Korea
Time of Update: 2022-08-22
Tariffs on masks and the core raw materials of masks are suspended Affected by the spread of the global epidemic, after the United States exempted more than 100 Chinese imported medical products from tariffs in early March, the Ministry of Planning and Finance of South Korea voted on the revision of the "Regulations on the Application of Tariff Quotas" at the State Council on March 17, and decided to target imports.
-
2022 Beijing Stroke First Aid Map Update Released
Time of Update: 2022-08-19
The Beijing Stroke Quality Control Center has updated and released the list of hospitals with stroke emergency treatment capabilities in Beijing based on the quantity and quality of intravenous thrombolysis for stroke in various hospitals in Beijing in 2021 .
-
The average salary of the 28 provinces has been released. Have the medical workers met the standard
Time of Update: 2022-08-15
Although the salary of the company's executives has raised the average salary, from the perspective of business development, it can also be seen that its rapid business development has affected the salary of employees of the company Among them, the per capita annual salary of Rejing Bio is as high as 885,000 yuan.
-
The State Food and Drug Administration cancels the medical device registration certificate of Tianzhihang Medical and other enterprises
Time of Update: 2022-08-15
, On May 10, in accordance with the "Regulations on the Supervision and Administration of Medical Devices", according to the application of enterprises, the State Food and Drug Administration cancelled the registration certificates of medical devices for 6 products below 3 companies including Shenzhen Boka Biotechnology Co.
-
Policy review: how provincial medical insurance policies inject new momentum into the development of traditional Chinese medicine
Time of Update: 2022-08-15
Gansu Province proposed to promote the development of "smart Chinese pharmacies", improve the level of pharmaceutical services such as TCM decoction pieces and formulations, and realize the integration of TCM decoction pieces procurement and storage, prescription circulation, medical insurance settlement, preparation and decoction, centralized distribution, and quality management in medical institutions.
-
STC2: a universal tumor biomarker and potential therapeutic target
Time of Update: 2022-08-12
1186/s13046-022-02370-wRecently, researchers from Tianjin Medical University Cancer Institute and Hospital published an article entitled "Stanniocalcin 2 (STC2): a universal tumor biomarker and a potential therapeutical target" in the journal J Exp Clin Cancer Res. The regulation, biological function and clinical significance in tumor are reviewed .
-
Domestic 15-valent HPV vaccine approved for clinical trial
Time of Update: 2022-04-25
The HPV market may usher in more strong competitors . Currently the world's highest HPV vaccine variety under developmentCurrently the world's highest HPV vaccine variety under developmentRecently, t
-
The "Tumor Immunity Xinhuo China" training program to improve the ability of standardized diagnosis and treatment of tumor immunity was officially launched
Time of Update: 2022-03-07
Unique - Immunotherapy reshapes the new pattern of first-line treatment of advanced liver cancer Moderator: Professor Zhou Jian, Zhongshan Hospital Affiliated to Fudan University Speaker: Professor Sun Huichuan, Zhongshan Hospital Affiliated to Fudan University Although TKIs are effective, the survival benefit is limited and a breakthrough is urgently needed .
-
The annual report performance of 8 pharmaceutical companies is good
Time of Update: 2022-02-18
The 2021 annual report performance forecast disclosed by Hualan shares shows that it is expected to achieve a net profit of 200 million to 240 million yuan in 2021, an increase of 145.
-
SHPL-49 injection, a new class 1 chemical drug of Shanghai Hutchison Pharmaceuticals, obtained NMPA and FDA clinical trial approval
Time of Update: 2021-11-04
The SHPL-49 injection was approved for clinical trials in China and the United States, marking the staged success of the collaborative innovation and achievement transformation of Shanghai University of Traditional Chinese Medicine and Shanghai Hutchison Pharmaceuticals .
-
The U.S. government encourages the expansion of domestic production capacity for single-use vaccine and drug production systems
Time of Update: 2021-10-20
” On October 7, BARDA announced a request for government funding to expand domestic production of disposable bags, pipes, and related components to support the new crown vaccine in a public health emergency.
